Showing 2851-2860 of 4163 results for "".
- BTL Files Patent Infringement Lawsuit Against WonderFace Devicehttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-wonderface-device/2483957/BTL Group has filed a patent infringement claim before the Unified Patent Court against Lexter Microelectronic Engineering Systems S.L., the company behind the WonderFace device. The claim centers on BTL’s proprietary technology used in its EMFACE system, which integrates selective muscle
- Registration Open for 2026 Octane Aesthetics Tech Forumhttps://modernaesthetics.com/news/registration-open-for-2026-octane-aesthetics-tech-forum/2483870/Aesthetic executives, leading physicians, and entrepreneurs will dive into the latest trends and technology in aesthetic medicine at the 2026 Octane Aesthetics Tech Forum. The 2-day forum will be held January 8-9 at the Pendry in Newport Beach, California. The agenda includes sessions on
- CollPlant Advances Light-Activated Regenerative Filler Toward Clinical Trialshttps://modernaesthetics.com/news/collplant-advances-light-activated-regenerative-filler-toward-clinical-trials/2483589/CollPlant Biotechnologies has announced the completion of a nonclinical program supporting the development of its photocurable dermal filler, which combines hyaluronic acid with a modified form of recombinant human collagen (rhCollagen). The company plans to advanc
- Dr. Anthony Brissett Named President of AAFPRS for 2025–2026 Termhttps://modernaesthetics.com/news/dr-anthony-brissett-named-president-of-aafprs/2483515/Anthony E. Brissett, MD, FACS, a facial plastic and reconstructive surgeon based in Houston, has been named President of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) for the 2025–2026 term. His appointment was formalized during the AAFPRS Annual Business Meeting held
- Allergan Aesthetics Launches Educational Campaign to Debunk Myths About HA Fillershttps://modernaesthetics.com/news/allergan-aesthetics-launches-educational-campaign-to-debunk-myths-about-ha-fillers/2483233/Allergan Aesthetics, an AbbVie company, has launched a new national campaign titled “Naturally You with Injectable Hyaluronic Acid Fillers,” aiming to counter widespread misinformation and educate both patients and healthcare providers on the safety and effectivenes
- Revance Brings Mepivacaine-Based Fillers to US Markethttps://modernaesthetics.com/news/revance-brings-mepivacaine-based-fillers-to-us-market/2483155/Revance has announced the US launch of the Teoxane RHA® Collection with Mepivacaine, marking a significant innovation in dermal filler formulations. The update reflects a shift in anesthetic agents used in hyaluronic acid fillers, with mepivacaine replacing lidocaine as the primary ane
- Innovative Hair Transplant Technique Combines MSCs to Enhance Hair Growthhttps://modernaesthetics.com/news/innovative-hair-transplant-technique-combines-mscs-to-enhance-hair-growth/2483096/New research published in Aesthetic Plastic Surgery reveals an innovative technique that may advance the treatment of baldness. In the article “Regenerative Hair Transplant: Innovation in Hair Transplantation Regenerative® Hair Transplant” the authors concluded that combining hair transp
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://modernaesthetics.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie
- ProRx Highlights Role of 503B Outsourcing in Patient-Centered Wellness Carehttps://modernaesthetics.com/news/prorx-highlights-role-503b-outsourcing-patient-centered-wellness-care/2476084/In recognition of National Wellness Month, ProRx, an FDA-registered 503B outsourcing facility, is emphasizing the clinical value of personalized, high-quality compounded therapies in wellness-focused care models. ProRx provides sterile and non-sterile compounded medications for office use
- Allergan Aesthetics Announces New ‘Faces of Natrelle’ Campaignhttps://modernaesthetics.com/news/allergan-aesthetics-announces-new-faces-of-natrelle-campaign/2476065/Allergan Aesthetics, an AbbVie company, has introduced “Faces of Natrelle,” a campaign centered on patient narratives surrounding breast augmentation and reconstruction using Natrelle silicone-filled breast implants. The initiative features 9 women selected through a national casting call,